United States · FDA National Drug Code directory
Hydromorphone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-1805_766e302a-2d03-4d93-b237-2348b57ee517
- Product NDC
- 0409-1805
- Form
- INJECTION, SOLUTION
- Composition / generic term
- HYDROMORPHONE HYDROCHLORIDE
- Labeler
- Hospira, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240129
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROMORPHONE HYDROCHLORIDE — .25 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CELLO PACK (0409-1805-01) / .5 mL in 1 SYRINGE (0409-1805-10) · 0409-1805-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →